PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

canSERV rolls out cancer research services across Europe

The European canSERV project – which aspires to defragment the landscape of European cancer research – commences in Brussels today.

Over the next three years, canSERV will enable academia and industry access to services and support from basic science up to clinical translation. The initiative aims to foster personalised medicine for cancer patients.

All services of the participating infrastructures will be linked on a common platform which will go online within the next few months. canSERV will connect, coordinate and align existing oncology and complementary research infrastructures alongside providing services synergistically. This will capitalise on the critical mass of experts and their extended networks.

canSERV aims to accelerate the process of translating theoretical knowledge into personalised oncology clinical practice, which will give cancer patients faster and easier access to solutions and products.

The project is aligned with the EU Cancer Mission declared by the European Commission last year, which suggested that taking interdisciplinary approaches could be the key to accelerating cancer research and finding new treatment options.

The canSERV project responds to this by providing new interdisciplinary and customised oncology services across the entire cancer continuum. This will provide a comprehensive portfolio of oncology-related research infrastructure services available to all EU member countries and beyond.

Professor Jens Habermann, canSERV Coordinator, explained: “The canSERV consortium will meet the needs of EU academic and industry users and create a more effective, streamlined and defragmented European oncology RI landscape.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026